welcome to oneFAPvoice
- a positively charged Familial Adenomatous Polyposis community.- join today!
- login
Celecoxib, DFMO combination improved adenoma burden in patients with familial adenomatous polyposis
In a randomized clinical chemoprevention trial, a combination of celecoxib and diflouromethylornithine resulted in a nonsignificant benefit among patients with familial adenomatous polyposis when adenoma count in a defined area was used as the primary endpoint. However, the combination was well tolerated, and a secondary measure of adenoma burden using a video-based global assessment showed a significant incremental benefit.
expertly curated content related to this topic
-
Proctocolectomy for Ulcerative Colitis or Familial Adenomatous Polyposishttps://www.youtube.com/watch?v=zlxBwxKX...
-
Duodenal Mucosal Risk Markers in Patients with Familial Adenomatous Polyposis: Effects of Celecoxib/Ursodeoxycholic ...BACKGROUND : Familial adenomatous polypo...
-
Emre I. Gorgun, MDDr. Gorgun obtained his Medical degree f...
-
Prevalence and Outcome of Anemia After Restorative Proctocolectomy: A Clinical Literature ReviewPURPOSE : Iron and/or vitamin B12 defici...
-
Food Fit for a Baby J-pouch: The Early Post-Proctocolectomy Diet (the newest fad diet)https://www.youtube.com/watch?v=ms8o1BBN...
-
Sulindac Sulfone Induced Regression of Rectal Polyps in Patients with Familial Adenomatous PolyposisSulindac sulfone (Exisulind), a metaboli...